vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Claritev Corp (CTEV). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $246.6M, roughly 1.1× Claritev Corp). BALCHEM CORP runs the higher net margin — 14.9% vs -32.7%, a 47.6% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs 6.2%). Claritev Corp produced more free cash flow last quarter ($36.4M vs $33.8M). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs 2.5%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
BCPC vs CTEV — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $246.6M |
| Net Profit | $40.3M | $-80.6M |
| Gross Margin | — | — |
| Operating Margin | 20.5% | -3.1% |
| Net Margin | 14.9% | -32.7% |
| Revenue YoY | 8.1% | 6.2% |
| Net Profit YoY | 8.7% | 41.6% |
| EPS (diluted) | $1.25 | $-4.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $246.6M | ||
| Q3 25 | $267.6M | $246.0M | ||
| Q2 25 | $255.5M | $241.6M | ||
| Q1 25 | $250.5M | $231.3M | ||
| Q4 24 | $240.0M | $232.1M | ||
| Q3 24 | $239.9M | $230.5M | ||
| Q2 24 | $234.1M | $233.5M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $-80.6M | ||
| Q3 25 | $40.3M | $-69.8M | ||
| Q2 25 | $38.3M | $-62.6M | ||
| Q1 25 | $37.1M | $-71.3M | ||
| Q4 24 | $33.6M | $-138.0M | ||
| Q3 24 | $33.8M | $-391.4M | ||
| Q2 24 | $32.1M | $-576.7M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | -3.1% | ||
| Q3 25 | 20.4% | 4.1% | ||
| Q2 25 | 20.1% | 6.9% | ||
| Q1 25 | 20.4% | 4.2% | ||
| Q4 24 | 19.8% | -17.8% | ||
| Q3 24 | 20.0% | -146.7% | ||
| Q2 24 | 19.6% | -224.4% |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | -32.7% | ||
| Q3 25 | 15.1% | -28.4% | ||
| Q2 25 | 15.0% | -25.9% | ||
| Q1 25 | 14.8% | -30.8% | ||
| Q4 24 | 14.0% | -59.4% | ||
| Q3 24 | 14.1% | -169.8% | ||
| Q2 24 | 13.7% | -247.0% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $-4.88 | ||
| Q3 25 | $1.24 | $-4.23 | ||
| Q2 25 | $1.17 | $-3.81 | ||
| Q1 25 | $1.13 | $-4.38 | ||
| Q4 24 | $1.03 | $-8.49 | ||
| Q3 24 | $1.03 | $-24.25 | ||
| Q2 24 | $0.98 | $-35.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $16.8M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $1.3B | $-173.9M |
| Total Assets | $1.7B | $4.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $16.8M | ||
| Q3 25 | $65.1M | $39.2M | ||
| Q2 25 | $65.4M | $56.4M | ||
| Q1 25 | $49.9M | $23.1M | ||
| Q4 24 | $49.5M | $16.8M | ||
| Q3 24 | $73.7M | $86.6M | ||
| Q2 24 | $63.7M | $48.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.5B |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $-173.9M | ||
| Q3 25 | $1.3B | $-101.8M | ||
| Q2 25 | $1.3B | $-39.9M | ||
| Q1 25 | $1.2B | $14.8M | ||
| Q4 24 | $1.1B | $84.0M | ||
| Q3 24 | $1.2B | $207.6M | ||
| Q2 24 | $1.1B | $603.4M |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $4.9B | ||
| Q3 25 | $1.7B | $5.0B | ||
| Q2 25 | $1.7B | $5.1B | ||
| Q1 25 | $1.6B | $5.1B | ||
| Q4 24 | $1.6B | $5.2B | ||
| Q3 24 | $1.6B | $5.3B | ||
| Q2 24 | $1.6B | $5.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 304.87× | ||
| Q4 24 | — | 53.67× | ||
| Q3 24 | — | 21.73× | ||
| Q2 24 | — | 7.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $66.3M |
| Free Cash FlowOCF − Capex | $33.8M | $36.4M |
| FCF MarginFCF / Revenue | 12.5% | 14.8% |
| Capex IntensityCapex / Revenue | 2.3% | 12.1% |
| Cash ConversionOCF / Net Profit | 0.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $66.3M | ||
| Q3 25 | $65.6M | $19.9M | ||
| Q2 25 | $47.3M | $61.2M | ||
| Q1 25 | $36.5M | $-30.1M | ||
| Q4 24 | $52.3M | $-33.4M | ||
| Q3 24 | $51.3M | $72.8M | ||
| Q2 24 | $45.0M | $18.5M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $36.4M | ||
| Q3 25 | — | $-16.3M | ||
| Q2 25 | — | $36.6M | ||
| Q1 25 | — | $-68.9M | ||
| Q4 24 | — | $-63.8M | ||
| Q3 24 | — | $41.1M | ||
| Q2 24 | — | $-7.0M |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | 14.8% | ||
| Q3 25 | — | -6.6% | ||
| Q2 25 | — | 15.2% | ||
| Q1 25 | — | -29.8% | ||
| Q4 24 | — | -27.5% | ||
| Q3 24 | — | 17.8% | ||
| Q2 24 | — | -3.0% |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 12.1% | ||
| Q3 25 | — | 14.7% | ||
| Q2 25 | — | 10.2% | ||
| Q1 25 | — | 16.8% | ||
| Q4 24 | — | 13.1% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 10.9% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
